Live Breaking News & Updates on Raju Mohan

Stay updated with breaking news from Raju mohan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Raju Mohan Sells 4,312 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) Stock

Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) CEO Raju Mohan sold 4,312 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $5.40, for a total transaction of $23,284.80. Following the transaction, the chief executive officer now directly owns 1,578,250 shares of […] ....

Raju Mohan , Ventyx Biosciences , Ventyx Biosciences Company Profile , Sphera Funds Management , Vanguard Group Inc , Canaccord Genuity Group , Capital Partners , Ventyx Biosciences Inc , Voloridge Investment Management , Wells Fargo Company , Get Free Report , Funds Management , Investment Management , Occudo Quantitative Strategies , Ventyx Biosciences Daily , Nasdaq Vtyx , Insider Trading , Nsider Trades ,

Ventyx Biosciences (NASDAQ:VTYX) Stock Price Up 5%

Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) rose 5% during mid-day trading on Tuesday . The company traded as high as $8.75 and last traded at $8.44. Approximately 937,127 shares were traded during trading, a decline of 82% from the average daily volume of 5,087,228 shares. The stock had previously closed at $8.04. Analyst […] ....

Ventyx Biosciences , Raju Mohan , John Nuss , Life Insurance Co , Ventyx Biosciences Company Profile , China Universal Asset Management Co , Securities Exchange Commission , Ventyx Biosciences Inc , Ameritas Investment Partners Inc , Group Plc , Wells Fargo Company , Get Free Report , Wells Fargo , Exchange Commission , Universal Asset Management , General Group Plc , Ameritas Investment Partners , Investment Partners , Ventyx Biosciences Daily , Nasdaq Vtyx ,

What's Going On With Ventyx Biosciences On Monday? - Ventyx Biosciences (NASDAQ:VTYX)

Ventyx Biosciences provides clinical and pipeline updates, revealing compelling results in NLRP3 inhibitor development. CEO Raju Mohan announces pipeline reprioritization and strategic financing for continued advancement. ....

Ventyx Biosciences , Ventyx Biosciences Inc , Raju Mohan , Key Symptom Score ,

Ventyx Biosciences (NASDAQ:VTYX) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS

Ventyx Biosciences (NASDAQ:VTYX) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raju Mohan , Stifel Nicolaus , Ventyx Biosciences , John Nuss , Pricet Rowe Associates Inc , Ventyx Biosciences Inc , Bridgeway Capital Management , Vanguard Group Inc , Securities Exchange Commission , Blackrock Inc , Wells Fargo Company , Get Free Report , Exchange Commission , Ventyx Biosciences Daily ,